div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=a-docs-a-pressrelease9m2018pdf-biocon-launches-krabeva-a-biosimilar-bevacizumabhtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: bioconcom › docs › PressRelease9m2018pdf · Biocon launches KRABEVA@ a biosimilar Bevacizumab in India for the treatment of patients with metastatic colorectal cancer and other loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentssitereader033viewer20220530185f1f2e976aed1745343e7803html5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=a-docs-a-pressrelease9m2018pdf-biocon-launches-krabeva-a-biosimilar-bevacizumabhtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: bioconcom › docs › PressRelease9m2018pdf · Biocon launches KRABEVA@ a biosimilar Bevacizumab in India for the treatment of patients with metastatic colorectal cancer and other loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentssitereader033viewer20220530185f1f2e976aed1745343e7803html5thumbnails2jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imageimg data-url=a-docs-a-pressrelease9m2018pdf-biocon-launches-krabeva-a-biosimilar-bevacizumabhtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: bioconcom › docs › PressRelease9m2018pdf · Biocon launches KRABEVA@ a biosimilar Bevacizumab in India for the treatment of patients with metastatic colorectal cancer and other loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentssitereader033viewer20220530185f1f2e976aed1745343e7803html5thumbnails3jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imageimg data-url=a-docs-a-pressrelease9m2018pdf-biocon-launches-krabeva-a-biosimilar-bevacizumabhtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: bioconcom › docs › PressRelease9m2018pdf · Biocon launches KRABEVA@ a biosimilar Bevacizumab in India for the treatment of patients with metastatic colorectal cancer and other loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentssitereader033viewer20220530185f1f2e976aed1745343e7803html5thumbnails4jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imageimg data-url=a-docs-a-pressrelease9m2018pdf-biocon-launches-krabeva-a-biosimilar-bevacizumabhtmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: bioconcom › docs › PressRelease9m2018pdf · Biocon launches KRABEVA@ a biosimilar Bevacizumab in India for the treatment of patients with metastatic colorectal cancer and other loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentssitereader033viewer20220530185f1f2e976aed1745343e7803html5thumbnails5jpg width=140 height=200 divdiv
